contributions.fyi

Bills · H.R. 747 · International Affairs

Stop Chinese Fentanyl Act of 2025

H.R. 747, introduced January 28, 2025 by Andy Barr (R-KY) with 9 cosponsors. Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. 1 organization reported lobbying on it from January 2025 through September 2026.

Passage votes
1Near-unanimous
Organizations lobbying on it
1
Said where they stood
0of 1, in their reports
Cosponsors
9

What the bill does

The Congressional Research Service's summary of the bill as introduced in the House, January 28, 2025. The version Congress voted on may differ.

This bill subjects certain Chinese entities and government officials to potential sanctions related to opioid trafficking and requires the President to conduct certain preliminary analyses before regulating economic transactions in the event of a national emergency related to international drug trafficking. 

Specifically, for the purposes of the Fentanyl Sanctions Act, the bill changes the definition of foreign opioid trafficker to specify that the term includes (1) Chinese entities involved in the production or sale of synthetic opioids or related pharmaceutical ingredients that fail to take steps to detect or prevent opioid trafficking; and (2) certain senior Chinese government officials that aid and abet opioid trafficking, including through intentional inaction. Under current law, the President must impose certain sanctions on individuals and entities identified as foreign opioid traffickers.

Further, the bill extends through 2029 an existing requirement that the President report to Congress annually on identified foreign opioid traffickers and any sanctions imposed on them. (This requirement expired in December 2024.)

The bill also requires the President to take additional steps in issuing regulations under the International Emergency Economic Powers Act (IEEPA) pursuant to a declared national emergency related to international drug trafficking. (IEEPA authorizes the President to regulate a variety of economic transactions following a declaration of national emergency.) Under the bill, the President must evaluate the costs and benefits of issuing economic regulations for the purpose of resolving the drug trafficking emergency and publish a discussion of such costs and benefits.

Read the full text on congress.gov or as a PDF (latest version: Referred in Senate, September 3, 2025)

How Congress voted

Each recorded vote on passing the bill, by party. Procedural votes (rules, motions to recommit, cloture) and amendments aren't shown: they mostly follow party lines whatever the bill says.

House, September 2, 2025 · Passage (two-thirds needed)

Near-unanimousNearly everyone agreed: Democrats voted 198–4 and Republicans 209–0. Passed, 2/3 needed.

  • Yes
  • No
  • Didn't vote
Democrats (198–4)Republicans (209–0)93%5%96%93% Yes96% YesDidn't vote 5%Didn't vote 4%

Who lobbied on it

Organizations whose quarterly lobbying reports name H.R. 747, January 2025 through September 2026. Reports list what was lobbied on, not the position taken: an organization here may have backed the bill, opposed it, or wanted one part of it changed. None of 1 said which in the report. Reports don't break spending down by bill, so there's no dollar figure for this one.

Organizations whose lobbying reports name H.R. 747
Organization, and what its report saysReportsSaid
FDD Action
…H.R. 2012, Iran Sanctions Relief Review Act of 2025, all provisions. H.R. 747, Stop Chinese Fentanyl Act of 2025, all provisions. H.R.1474, International Nuclear Energy Financing Act of 2025, all…
3 quarters, 2025 Q1 to 2025 Q3—

Committees

Where it was referred or reported from.

Subjects

As indexed by the Library of Congress.

  • Asia
  • China
  • Civil actions and liability
  • Congressional oversight
  • Drug trafficking and controlled substances
  • Presidents and presidential powers, Vice Presidents
  • Sanctions
  • Smuggling and trafficking

Bill details from congress.gov (GovInfo bill status data, 119th Congress); summaries by the Congressional Research Service. Votes from the House Clerk and the Senate. Lobbying from quarterly LD-2 reports on lda.gov, matched by the bill number written in each report. How bills are matched.